Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:INTS

Intensity Therapeutics (INTS) Stock Price, News & Analysis

Intensity Therapeutics logo

About Intensity Therapeutics Stock (NASDAQ:INTS)

Advanced Chart

Key Stats

Today's Range
$2.36
$2.79
50-Day Range
N/A
52-Week Range
$0.26
$5.10
Volume
73,559 shs
Average Volume
431,470 shs
Market Capitalization
$8.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.50
Consensus Rating
Moderate Buy

Company Overview

Intensity Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
31st Percentile Overall Score

INTS MarketRank™: 

Intensity Therapeutics scored higher than 31% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Intensity Therapeutics has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Intensity Therapeutics has only been the subject of 1 research reports in the past 90 days.

  • Read more about Intensity Therapeutics' stock forecast and price target.
  • Earnings Growth

    Earnings for Intensity Therapeutics are expected to grow in the coming year, from ($1.18) to ($1.00) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Intensity Therapeutics is -0.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Intensity Therapeutics is -0.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Intensity Therapeutics has a P/B Ratio of 1.62. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    6.58% of the float of Intensity Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Intensity Therapeutics has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Intensity Therapeutics has recently increased by 42.89%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Intensity Therapeutics does not currently pay a dividend.

  • Dividend Growth

    Intensity Therapeutics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.58% of the float of Intensity Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Intensity Therapeutics has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Intensity Therapeutics has recently increased by 42.89%, indicating that investor sentiment is decreasing significantly.
  • Search Interest

    6 people have searched for INTS on MarketBeat in the last 30 days. This is an increase of 500% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Intensity Therapeutics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    17.10% of the stock of Intensity Therapeutics is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 3.74% of the stock of Intensity Therapeutics is held by institutions.

  • Read more about Intensity Therapeutics' insider trading history.
Receive INTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intensity Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

INTS Stock News Headlines

Trump set to Boost Social Security Checks by 400%?
If you're collecting—or plan to collect—Social Security, this could be a game-changer. A new initiative tied to President Trump's Executive Order #14196 could not only rescue Social Security... But also boost benefits by up to 400%, according to legendary investor Louis Navellier.
See More Headlines

INTS Stock Analysis - Frequently Asked Questions

Intensity Therapeutics Inc. (NASDAQ:INTS) announced its quarterly earnings data on Tuesday, May, 13th. The company reported ($0.22) earnings per share for the quarter, missing analysts' consensus estimates of ($0.21) by $0.01.

Intensity Therapeutics (INTS) raised $20 million in an initial public offering on Friday, June 30th 2023. The company issued 3,900,000 shares at a price of $5.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that Intensity Therapeutics investors own include Amgen (AMGN), Costco Wholesale (COST), Cisco Systems (CSCO), Honeywell International (HON), Intel (INTC), Intuitive Surgical (ISRG) and Mondelez International (MDLZ).

Company Calendar

Last Earnings
5/13/2025
Today
7/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED-BIOMED/GENE
Sub-Industry
N/A
Current Symbol
NASDAQ:INTS
CIK
1567264
Fax
N/A
Employees
2,021
Year Founded
N/A

Price Target and Rating

High Price Target
$12.00
Low Price Target
$5.00
Potential Upside/Downside
+2,659.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.27 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$0.19 per share
Price / Book
1.62

Miscellaneous

Free Float
20,786,000
Market Cap
$7.72 million
Optionable
Not Optionable
Beta
3.27
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:INTS) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners